NO20006543L - Carotenanalog av porfyriner, chloriner og bacteriochloriner som terapeutiske og diagnostiske midler - Google Patents

Carotenanalog av porfyriner, chloriner og bacteriochloriner som terapeutiske og diagnostiske midler

Info

Publication number
NO20006543L
NO20006543L NO20006543A NO20006543A NO20006543L NO 20006543 L NO20006543 L NO 20006543L NO 20006543 A NO20006543 A NO 20006543A NO 20006543 A NO20006543 A NO 20006543A NO 20006543 L NO20006543 L NO 20006543L
Authority
NO
Norway
Prior art keywords
carotene
bacteriochlorines
chlorines
porphyrins
analogue
Prior art date
Application number
NO20006543A
Other languages
English (en)
Other versions
NO20006543D0 (no
Inventor
Ravindra K Pandey
William R Potter
Thomas J Dougherty
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Publication of NO20006543D0 publication Critical patent/NO20006543D0/no
Publication of NO20006543L publication Critical patent/NO20006543L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Carotenkonjugat med formel (I), hvor R1 er hydrogen eller metyl; R2 er formel (a); R3, R4 og R5 er uavhengig hydrogen, metyl eller etyl; R6 og R7 er uavhengig -R13, -OR13, -C(R16)(O), -C(R16)2OR13, -CH=CHR13, eller -(CH2)R14; R8 er -R13, -OR13, -C(R16)(O), -C(R16)2OR13, -CH=CHR13, eller -(CH2)R14 eller er sammen med R10 =O; R9 er -R13, -OR13, -C(R16)(O), -C(R16)2OR13, -CH=CHR13, eller -(CH2)R14 eller er sammen med R10 en kjemisk binding; R10 er-R13, -OR13, -C(R16)(O), -C(R16)2OR13, -CH=CHR13, eller-(CH2)R14 eller er sammen med R9 er en kjemisk binding, eller er sammen med R8 =O; R11 er R13 eller -OR13, R12 er -C(R13)2C(Y)-, -C(O)O(O)C-, -C(NR13)O(O)C-, eller - C(O)N(R15)-C(O)-; R13 er uavhengig i hvert tilfelle hydrogen eller lavere alkyl med fra 1 til og med ca. 10 karbonatomer; R14 er en aminosyrerest, R15 er -R13, -R14, eller -C(0)NHR13; R16 er uavhengig i hvert tilfelle hydrogen eller lavere alkyl med 1 til ca. 4 karbonatomer og Y er =O, =S, eller 2H-.
NO20006543A 1998-06-22 2000-12-21 Carotenanalog av porfyriner, chloriner og bacteriochloriner som terapeutiske og diagnostiske midler NO20006543L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/102,417 US6103751A (en) 1998-06-22 1998-06-22 Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents
PCT/US1999/012170 WO1999067248A1 (en) 1998-06-22 1999-06-01 Carotene analog of porhyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents

Publications (2)

Publication Number Publication Date
NO20006543D0 NO20006543D0 (no) 2000-12-21
NO20006543L true NO20006543L (no) 2001-02-14

Family

ID=22289740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006543A NO20006543L (no) 1998-06-22 2000-12-21 Carotenanalog av porfyriner, chloriner og bacteriochloriner som terapeutiske og diagnostiske midler

Country Status (6)

Country Link
US (1) US6103751A (no)
EP (1) EP1087974A4 (no)
CA (1) CA2331763A1 (no)
MX (1) MXPA00013021A (no)
NO (1) NO20006543L (no)
WO (1) WO1999067248A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
WO2000041726A2 (en) 1999-01-15 2000-07-20 Light Sciences Corporation Noninvasive vascular therapy
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
JP2002534483A (ja) * 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 代謝性骨障害または骨転移のための治療的組成物
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US7166719B2 (en) * 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6534040B2 (en) * 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7078014B2 (en) * 1999-12-23 2006-07-18 Health Research, Inc. Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7097826B2 (en) * 1999-12-23 2006-08-29 Health Research, Inc. Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
AU2003249742A1 (en) 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
US7057100B2 (en) * 2003-06-26 2006-06-06 The J.C. Robinson Seed Co. Inbred corn line W23129
WO2005048944A2 (en) * 2003-11-14 2005-06-02 University Of Pennsylvania Activatable photodynamic therapy agents
RU2259200C1 (ru) * 2004-02-16 2005-08-27 Рузиев Рамзес Джауланович Сенсибилизатор для фотодинамического разрушения клеток злокачественных новообразований и фармацевтическая композиция с его использованием
US7947729B2 (en) * 2004-07-16 2011-05-24 Health Research, Inc. Adduct of fluorescent dye and tumor avid tetrapyrrole
US7147840B2 (en) * 2004-11-24 2006-12-12 Health Research, Inc. Oxo-bacteriopyropheophorbide-a carboxylic acid and esters thereof
US20110070154A1 (en) * 2008-08-13 2011-03-24 Hyde Roderick A Artificial cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US5198460A (en) * 1988-07-20 1993-03-30 Health Research Inc. Pyropheophorbides and their use in photodynamic therapy
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5238940A (en) * 1990-03-22 1993-08-24 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5286474A (en) * 1992-10-22 1994-02-15 Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf The Arizona State University Use of carotenoporphyrins as tumor localizing agents for diagnosis
US5498710A (en) * 1994-04-22 1996-03-12 Health Research, Inc. Alkyl ether analogues of benzoporphyrin derivatives
US5591847A (en) * 1994-05-23 1997-01-07 Health Research, Inc. Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages
US5637608A (en) * 1995-04-06 1997-06-10 Cytopharm, Inc. 9-substituted porphycenes
US6008211A (en) * 1995-07-27 1999-12-28 Pdt Pharmaceuticals, Inc. Photoactivatable compounds comprising benzochlorin and furocoumarin

Also Published As

Publication number Publication date
US6103751A (en) 2000-08-15
EP1087974A4 (en) 2002-10-30
NO20006543D0 (no) 2000-12-21
CA2331763A1 (en) 1999-12-29
MXPA00013021A (es) 2003-07-14
WO1999067248A1 (en) 1999-12-29
EP1087974A1 (en) 2001-04-04

Similar Documents

Publication Publication Date Title
NO20006543L (no) Carotenanalog av porfyriner, chloriner og bacteriochloriner som terapeutiske og diagnostiske midler
Gudasheva et al. Synthesis and antiamnesic activity of a series of N-acylprolyl-containing dipeptides
US4772587A (en) Dipeptide derivative of fatty acid
DE60119968T2 (de) Hepatitis c tripeptid inhibitoren
ES2543840T3 (es) Inhibidores espirocíclicos del VHC/VIH y sus usos
EP0073143B1 (en) Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides
CA2075154A1 (en) Peptide aldehydes as antithrombotic agents
MY119011A (en) Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
BR9913646B1 (pt) Tripeptídeos inibidores da hepatite C, composição farmacêutica compreendendo os mesmos, seu isômero óptico, uso e processo para sua preparação
CA2140598A1 (en) Prolineamide derivatives
KR910011891A (ko) 펩티드 화합물, 이의 제조방법 및 이를 함유하는 약학적 조성물
KR880003974A (ko) 디아민의 선택적 아미딘화 방법
ZA804787B (en) 4-benzyl- and 4-benzoyl imidazole derivatives, pharmaceutical compositions containing the same, their preparation and their use
CA2064815A1 (en) Therapeutic heterocyclic compounds
AU2008217187A1 (en) Macrocyclic compounds as HCV NS3 protease inhibitors
CA2256582A1 (en) Oxa acids and related compounds for treating skin conditions
CZ20033413A3 (cs) @@Fluorpyrrolidiny jako antidiabetická činidla
CA2047496A1 (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
WO2002090375A8 (en) Liver x receptor agonists
MX9605156A (es) Inhibidor de angiogenesis.
NO924929L (no) Farmasoeytisk aktive benzoquinazolinforbindelser
CA2407659A1 (en) Growth hormone secretagogues
JPH01113353A (ja) 抗高血圧剤としてのα−アミノアシルβ−アミノアシルアミノジオール
KR850004472A (ko) 4h-3,i-벤즈옥사진-4-온 유도체의 제조방법
KR100341982B1 (ko) 프롤릴엔도펩티다제억제제

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application